文献速递临床试验与 GCP真实世界研究与卫生经济

MiLES干预雇主促进癌症员工成功复工:试点随机对照试验设计

The MiLES intervention targeting employers to promote successful return to work of employees with cancer: design of a pilot randomised controlled trial.
PubMed 文献 · Trials · 2020-04-28

本研究设计一项试点随机对照试验,旨在评估针对雇主的在线工具箱MiLES干预在癌症员工复工中的可行性。计划纳入90名确诊癌症不足2年、在职且病假不足1年的18-63岁员工,随机分为干预组和对照组,随访6个月,主要结局为员工自评的成功复工。

要点

  • 试点试验旨在评估未来确定性RCT的可行性,并初步探索干预效果。
  • 干预为在线工具箱,要求员工告知雇主使用以支持复工过程。
  • 主要效果指标为癌症幸存者自我感知的成功复工。

核心结论

  • 该试点RCT设计旨在确定未来研究MiLES干预对癌症员工成功复工有效性的RCT是否可行。

研究设计与样本

  • 采用试点随机对照试验,随访6个月,计划通过荷兰医院医疗专家招募90名参与者。
  • 纳入标准:确诊癌症不足2年、年龄18-63岁、有雇主且带薪就业、当前病假或部分病假不足1年。

主要发现

  • 原文未报告试点试验的结果,因本文为设计论文。

关键数值与推荐

  • 可行性将基于方法学不确定性和研究方案可接受性的标准进行评估。
  • 主要效果指标为成功复工,即癌症幸存者自身认为复工成功,用于未来确定性RCT的样本量计算。

临床怎么用

  • 若可行性得到证实,未来确定性RCT可评估MiLES干预对癌症员工成功复工的有效性。

局限性

  • 原文未报告研究的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Employers express a need for support to facilitate the return to work (RTW) process of employees with cancer. We have developed the MiLES intervention, an online toolbox targeting employers during the RTW of employees with cancer. To evaluate the MiLES intervention, we propose the design of a pilot randomised controlled trial (RCT). The aim of this pilot is to determine whether a future RCT to study the effectiveness of this intervention on successful RTW of employees with cancer is feasible. Secondary aims are to obtain preliminary results on the effectiveness of the intervention and to determine the sample size needed in a future definitive RCT. METHODS: A pilot RCT with a 6-month follow-up will be conducted. Using medical specialists at Dutch hospitals, we aim to enrol 90 participants diagnosed with cancer (<2 years earlier) aged 18-63 years who are in paid employment with an employer and who are currently sick-listed or partly sick-listed for <1 year. Participants randomised to the intervention group will be asked to inform their employer about the online toolbox supporting employers during the RTW process of employees with cancer. Participants in the control group will receive 'care as usual' from their employer. All measures will be assessed at the level of the employee using questionnaires at baseline and after 3 and 6 months of follow-up. The feasibility of a future RCT will be determined using criteria concerning method-related uncertainties and acceptability of the study protocol. The primary effect measure will be successful RTW (that is, RTW perceived as being successful by the cancer survivor themselves). This effect measure will be used to perform the sample size calculation for a future definitive RCT. DISCUSSION: The design is proposed to determine the feasibility to study the effectiveness of the MiLES intervention targeting employers on the successful RTW of employees diagnosed with cancer. This pilot RCT can increase the probability of a successful future definitive RCT on the effectiveness of the intervention and potentially obviate the need to carry out an unfeasible and resource-intensive study. TRIAL REGISTRATION: Dutch Trial Register (NTR): NL6758, NTR7627. Registered on 30 October 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Greidanus MA, de Boer AGEM, de Rijk AE, et al. The MiLES intervention targeting employers to promote successful return to work of employees with cancer: design of a pilot randomised controlled trial. Trials. 2020. PMID: 32345344. doi:10.1186/s13063-020-04288-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。